AIG
CRBP icon

American International Group’s Corbus Pharmaceuticals CRBP Stock Holding History

American International Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,492
Closed -$88 – 3149
2021
Q1 		$88 Buy
1,492
+4
+0.3% +$263 ﹤0.01% 2775
2020
Q4 		$56 Sell
1,488
-1
-0.1% -$37 ﹤0.01% 2926
2020
Q3 		$80K Buy
1,489
+138
+10% +$25K ﹤0.01% 2645
2020
Q2 		$340K Buy
1,351
+52
+4% +$10.5K ﹤0.01% 1797
2020
Q1 		$204K Buy
1,299
+60
+5% +$10.1K ﹤0.01% 1889
2019
Q4 		$203K Sell
1,239
-10
-0.8% -$1.48K ﹤0.01% 2212
2019
Q3 		$183K Sell
1,249
-9
-0.7% -$1.57K ﹤0.01% 2223
2019
Q2 		$262K Buy
1,258
+96
+8% +$20.6K ﹤0.01% 2057
2019
Q1 		$242K Buy
1,162
+67
+6% +$14.8K ﹤0.01% 2114
2018
Q4 		$192K Sell
1,095
-8
-0.7% -$1.6K ﹤0.01% 2204
2018
Q3 		$250K Buy
1,103
+20
+2% +$3.23K ﹤0.01% 2299
2018
Q2 		$164K Buy
1,083
+36
+3% +$6.54K ﹤0.01% 2482
2018
Q1 		$192K Sell
1,047
-41
-4% -$9.21K ﹤0.01% 2285
2017
Q4 		$232K Buy
1,088
+98
+10% +$21K ﹤0.01% 2232
2017
Q3 		$212K Buy
990
+74
+8% +$14.5K ﹤0.01% 2259
2017
Q2 		$173K Buy
+916
New +$180K ﹤0.01% 2360

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

American International Group's CRBP Position: Q2 2021 in Review

American International Group sold out of Corbus Pharmaceuticals (CRBP) in Q2 2021, closing a stake of 1,492 shares — an estimated $88 sold.

American International Group first reported a position in CRBP in Q2 2017 and held it in 16 quarters. The position peaked at $340K in Q2 2020. 98 funds tracked by Wall St. Rank hold CRBP as of Q2 2021.

  • American International Group reported no remaining Corbus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 1,492 Corbus Pharmaceuticals shares in Q2 2021, an estimated $88.
  • American International Group first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 16 quarters.
  • American International Group's Corbus Pharmaceuticals position peaked at $340K in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.